Provided by Tiger Fintech (Singapore) Pte. Ltd.

SciSparc Ltd.

0.3750
+0.03008.70%
Post-market: 0.3462-0.0288-7.68%19:52 EDT
Volume:358.19K
Turnover:129.95K
Market Cap:4.06M
PE:-0.07
High:0.3802
Open:0.3495
Low:0.3475
Close:0.3450
Loading ...

Press Release: SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

Dow Jones
·
26 Dec 2024

SciSparc amends non-binding LOI to spin-off advanced clinical stage portfolio

TIPRANKS
·
16 Dec 2024

BRIEF-Scisparc Provides Updates On Status Of Spin-Off Of Its Advanced Clinical Stage Pharmaceutical Portfolio

Reuters
·
16 Dec 2024

Scisparc Provides Updates on Status of Spin-off of Its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company

THOMSON REUTERS
·
16 Dec 2024

SciSparc Ltd. to Acquire AutoMax Motors Ltd.

TIPRANKS
·
29 Nov 2024

BRIEF-Scisparc Ltd Entered Into Second Addendum To Merger Agreement With Automax Motors Ltd And Scisparc Merger Sub Ltd

Reuters
·
28 Nov 2024

SciSparc Extends Merger Deadline with AutoMax Motors

TIPRANKS
·
28 Nov 2024

Scisparc Ltd: Right to Terminate Merger Agreement IF Merger Was Not Consummated by Nov 30, 2024, Was Deferred to March 31, 2025

THOMSON REUTERS
·
28 Nov 2024

Scisparc Ltd: Entered Into Second Addendum to Merger Agreement With Automax Motors Ltd and Scisparc Merger Sub Ltd

THOMSON REUTERS
·
28 Nov 2024

SciSparc Ltd. Reports Changes in Financial Position

TIPRANKS
·
05 Nov 2024

SciSparc Ltd. Gains Shareholder Approval for Proposals

TIPRANKS
·
23 Oct 2024

SciSparc Ltd. Reschedules Annual General Meeting

TIPRANKS
·
23 Oct 2024

Scisparc Secures FDA Green Light to US Launch of Its Pivotal Phase Iib Clinical Trial for Breakthrough Tourette Syndrome Treatment

THOMSON REUTERS
·
30 Sep 2024

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

GlobeNewswire
·
30 Sep 2024

SciSparc Ltd. Proposes Reverse Stock Split

TIPRANKS
·
28 Sep 2024

BRIEF-Scisparc Signs Non-Binding Letter Of Intent To Sell Stake In Mitocarex

Reuters
·
26 Sep 2024